KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Total Liabilities (2016 - 2026)

Bristol Myers Squibb has reported Total Liabilities over the past 18 years, most recently at $66.4 billion for Q1 2026.

  • Quarterly Total Liabilities fell 11.48% to $66.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $66.4 billion through Mar 2026, down 11.48% year-over-year, with the annual reading at $71.5 billion for FY2025, 6.14% down from the prior year.
  • Total Liabilities was $66.4 billion for Q1 2026 at Bristol Myers Squibb, down from $71.5 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $82.5 billion in Q1 2024 and troughed at $61.5 billion in Q2 2023.
  • The 5-year median for Total Liabilities is $71.4 billion (2022), against an average of $70.8 billion.
  • Year-over-year, Total Liabilities dropped 12.6% in 2023 and then soared 32.19% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $65.7 billion in 2022, then dropped by 0.04% to $65.7 billion in 2023, then rose by 16.05% to $76.2 billion in 2024, then fell by 6.14% to $71.5 billion in 2025, then fell by 7.21% to $66.4 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Total Liabilities are $66.4 billion (Q1 2026), $71.5 billion (Q4 2025), and $78.3 billion (Q3 2025).